16:8 Time-Restricted Feeding Cut Crohn's Disease Activity by 40% in 12 Weeks: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

What This Study Looked At

Researchers at UBC Okanagan and the University of Calgary wanted to know whether simply restricting the hours of the day when Crohn's disease patients eat — without telling them to change what they eat — could reduce gut inflammation and improve their symptoms. Crohn's disease is a chronic inflammatory bowel condition affecting around 3 million people in North America, characterised by abdominal pain, diarrhoea, and persistent gut inflammation. Current treatments rely heavily on medication; this study asked whether meal timing alone could act as an adjunct therapy. Understanding this link between intermittent fasting and gut health matters not only for Crohn's patients but for anyone using time-restricted eating to reduce systemic inflammation.

Who Was Studied

Participant profile: Median age 49 years; 63% female; median BMI 28.0 kg/m² (overweight); median fecal calprotectin 115 mcg/g at baseline; all had established Crohn's disease and were overweight or obese.

How 16:8 time-restricted feeding worked in this study: Participants chose their own 8-hour eating window each day and fasted (water, black coffee, and plain tea allowed) for the remaining 16 hours. This was followed 6 days per week — one "rest day" per week was permitted. No changes to the composition of their diet were required.

What the Researchers Found

Clinical Disease Activity

Key clinical findings:

• Crohn's disease clinical disease activity fell by approximately 40% in the TRF group compared to no significant change in standard management
• Abdominal discomfort reduced by approximately 50% in TRF participants
• A meaningful proportion of TRF participants moved from active disease toward remission scores by week 12

Body Composition

• BMI decreased significantly in the TRF group
• Visceral abdominal fat — the metabolically active fat surrounding the internal organs — was meaningfully reduced with TRF
• Controls gained weight over the same 12-week period

Systemic Inflammation

• Inflammatory biomarkers improved significantly in the TRF group
• Markers of immune system activity and systemic inflammation were reduced compared to the standard management group
• The authors describe the effect as "halved inflammation" over the 12 weeks

What Did Not Change

• The study did not require dietary composition changes, and none were controlled
• Medication regimens were maintained throughout — the TRF effect was observed on top of existing drug therapies, not instead of them

What the Researchers Concluded

Simply restricting the hours of eating to an 8-hour window, without changing what patients ate, was sufficient to produce meaningful reductions in Crohn's disease activity, systemic inflammation, and body weight within 12 weeks. The researchers concluded that time-restricted feeding represents a promising, low-cost dietary adjunct for people with Crohn's disease who are overweight.

What This Means If You Fast

• Gut inflammation and eating timing are directly linked. This study demonstrates that meal timing — independent of diet quality — affects systemic and intestinal inflammation. The fasting window appears to give the gut rest it needs to reduce inflammatory activity.
• The 16:8 protocol produced real clinical outcomes in a difficult-to-treat condition. If a 40% reduction in disease activity occurred in Crohn's patients (whose inflammation is severe and chronic), the anti-inflammatory effect in healthy people using 16:8 fasting is likely meaningful too.
• You do not need to fast every day of the week. The protocol here was 6 days per week. One flexible day was sufficient to maintain the protocol without negating the results.
• Weight and inflammation are connected. Participants who lost visceral fat also had the greatest improvements in inflammatory markers. The weight loss from fasting is not cosmetic — it appears to drive real biological changes in the gut.
• TRF may complement, not replace, medical treatment. The results came on top of existing medication. Anyone with a diagnosed gut condition should discuss fasting as an adjunct with their gastroenterologist, not as a standalone therapy.
• Starting a 16:8 window is accessible. Unlike dietary interventions that require specific foods or preparation, this protocol only required changing when participants ate — not what they ate. This makes it one of the most practical diet-based interventions studied in IBD to date.

Study Limitations

• Small sample size (n=35 completers) — this is a pilot study and findings need replication in larger trials
• Participants were overweight Crohn's disease patients — results may not generalise directly to healthy-weight individuals or other inflammatory gut conditions
• 63% female sample — male-specific findings cannot be separated from the overall results
• No control for dietary composition — participants may have eaten better or differently simply by having a structured eating window
• Short duration (12 weeks) — long-term effects of TRF on Crohn's disease activity are unknown
• Medication use varied across participants — some were on biologics, others on 5-ASA or corticosteroids, making it difficult to isolate TRF's effect
• Funding from the Crohn's & Colitis Foundation — a legitimate research funder, though disease-specific funding should be noted

Source

Haskey N, Ye J, Lewis A, Yousuf M, Reimer RA, Raman M. (2026). Time-Restricted Feeding Reduces Body Mass Index, Visceral Adiposity, Systemic Inflammation, and Clinical Disease Activity in Adults With Crohn's Disease: A Randomized Controlled Study. Gastroenterology. DOI: 10.1053/j.gastro.2025.11.008

Frequently Asked Questions

Does intermittent fasting help Crohn's disease?

This 2026 randomized controlled trial found that 16:8 time-restricted feeding for 12 weeks reduced Crohn's disease clinical activity by approximately 40% and abdominal discomfort by approximately 50%, compared to no significant change in the standard management group. While this is a pilot study requiring replication, the results are clinically significant.

What fasting protocol was used in the Crohn's study?

Participants ate within an 8-hour daily window of their own choosing and fasted for 16 hours on 6 days per week (one flexible day was permitted). They did not change the types of food they ate — only when they ate.

Can 16:8 fasting reduce gut inflammation?

The trial suggests yes. The 16-hour fasting window appeared to give the intestinal tract time to reduce inflammatory signalling, even without changes to diet composition. Inflammatory biomarkers fell significantly in the TRF group, with researchers describing the effect as approximately halving systemic inflammation over 12 weeks.

Should people with Crohn's disease try intermittent fasting?

The study was conducted alongside existing medical treatment — not as a replacement. Anyone with Crohn's disease or another inflammatory bowel condition should discuss intermittent fasting with their gastroenterologist before starting, particularly if they are on immunosuppressant or steroid medication.

What happened to weight in the study?

The TRF group lost approximately 2.5 kg (5.5 lbs) over 12 weeks. The standard management group gained approximately 1.7 kg (3.7 lbs) over the same period. Visceral abdominal fat — the fat most closely linked to systemic inflammation — also decreased significantly in the TRF group.

Is this study relevant to people who don't have Crohn's disease?

The anti-inflammatory and weight-loss effects seen in Crohn's patients are consistent with what other IF trials have found in metabolically healthy people. The gut-rest mechanism (giving the intestinal lining extended periods without food processing) is not unique to Crohn's — it's a general biological response to fasting that is relevant to anyone with inflammatory conditions or excess visceral fat.

Related Research and Articles

• Intermittent fasting and gut health: what the science shows
• Does intermittent fasting reduce inflammation?
• What is the 16:8 intermittent fasting protocol?
• Intermittent fasting and inflammation: the research explained
• Can intermittent fasting help with IBS or digestive issues?
• Intermittent fasting and autophagy explained
• Gut microbiome changes during Ramadan fasting: what a 2021 study found

Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.